Sangamo Therapeutics, Inc. (SGMO) - Multiplikator Forward P/S

Logo korporat perusahaan Sangamo Therapeutics Inc. (SGMO)

Sangamo Therapeutics (SGMO) profit potential relies on the licensing of zinc finger technologies and payments from industry behemoths. Drug development is automated using AI, although final tests require physician involvement. The forward price-to-sales valuation trend reflects current market dynamics, where 1.90 is the relevant value of the indicator. This chart highlights the company's strong scientific workforce and patent portfolio.

SGMO sangamo.com: Rega forward marang dodolan ing interval 04.07.2022 - 09.05.2026

Rincian metrik keuangan lan pasar Sangamo Therapeutics (SGMO)

- rega saiki lan proyeksi nilai saham:
Analisis wiwitan perusahaan:Sangamo Therapeutics Inc. (SGMO)
Produk asli Sangamo BioSciences

Forward P/S measures market capitalization relative to expected sales volume, allowing investors to assess the degree of optimism priced in and the risk of overpaying for future earnings. The forward price-to-sales analysis for Sangamo Therapeutics (SGMO) accounts for the impact of "zinc finger" patent protection and prolonged regulatory cycles, confirming the fundamental resilience of the business through a balance of market expectations and technological barriers.

Pesaing Sangamo Therapeutics

Multiplikator Forward P/S TEM (Tempus Labs)|Qiagen N.V. - Rasio rega marang prakiraan pendapatan|IONS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep repligen.com|RNA: Multiplikator Forward P/S|CRISPR Therapeutics Inc (CRSP) - Multiplikator Forward P/S|WGS (GeneDx Holdings) - Multiplikator Forward P/S|RARE: Rega forward marang dodolan|Multiplikator forward rega marang pendapatan BEAM (Beam Therapeutics Corp)|SRPT: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S TWST (Twist Bioscience Inc)|Rasio kapitalisasi marang dodolan sing dikarepake 10x Genomics Corp (TXG)|intelliatx.com - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Stoke STOK|biolifesolutions.com (BLFS) - Rasio rega marang prakiraan pendapatan|WVE - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan MAZE|Multiplikator forward rega marang pendapatan Sionna Therapeutics, Inc. (SION)|Multiplikator forward rega marang pendapatan PRME (Prime Medicine Bio)|Rasio kapitalisasi marang dodolan sing dikarepake Taysha|uniQure Pharma - Multiplikator forward rega marang pendapatan|MeiraGTx Holdings plc - Rasio rega marang prakiraan pendapatan|regenxbio.com - Multiplikator Forward P/S|Solid Bio (SLDB) - Multiplikator forward rega marang pendapatan|OCGN: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Pacific Biosciences of California|BNTC (Benitec Biopharma Inc.) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan DSGN (Design Therapeutics)|Multiplikator Forward P/S RCKT|Rasio rega marang prakiraan pendapatan FDMT (4D Molecular Therapeutics Inc)|Multiplikator Forward P/S LXEO (Lexeo Therapeutics Inc.)|Rega forward marang dodolan KRRO|EDIT - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Silence Therapeutics SLN|ProQR Therapeutics NV (PRQR) - Rasio rega marang prakiraan pendapatan|Codexis Inc - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Nautilus Bio|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Metagenomi Therapeutics MGX|Rasio rega marang prakiraan pendapatan Precision BioSciences (DTIL)|GBIO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S BOLD (Boundless Bio, Inc)|XCUR - Multiplikator forward rega marang pendapatan|IMNN - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Phio Pharmaceuticals Corp|MBIO: Multiplikator Forward P/S|TransCode (RNAZ) - Multiplikator Forward P/S|BNGO (Bionano) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Applied DNA Sciences, Inc. APDN|Multiplikator Forward P/S BLUE|ImmunoPrecise Antibodies Ltd - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Omega Therapeutics OMGA|OMIC: Kapitalisasi marang prakiraan pendapatan|RGLS: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan SYRS (Syros Pharmaceuticals, Inc.)|Telesis Bio, Inc. (TBIO) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TCON (TRACON)|Rasio rega marang prakiraan pendapatan Unity Biotechnology, Inc.